Credit:
Researchers used a systematic computational approach to develop individualized pathways for therapy in metastatic prostate cancer. As shown in the diagram they integrated gene expression and new phosphoproteomic information from the analysis of clinical prostate cancer tissues to develop personalized pathway networks for six individual patients, revealing common and distinct signaling mechanisms whose details suggest targets for therapeutic consideration.